OncoGenex Pharma (OGXI) Tops Q1 EPS by 14c

OncoGenex Pharma (NASDAQ: OGXI) reported Q1 EPS of ($0.20), $0.14 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $1.4 million versus the consensus estimate of $4.66 million.

For earnings history and earnings-related data on OncoGenex Pharma (OGXI) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• La-Z-Boy (LZB) Misses Q1 EPS by 6c, Misses on Revenue; Offers Weak Q2 Revenue Guidance
• Evolution Petroleum launches stock offering to fund Permian Basin deal